Wells Fargo’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.48M | Buy |
110,116
+6,336
| +6% | +$200K | ﹤0.01% | 2478 |
|
|
2025
Q1 | $3.44M | Buy |
103,780
+85,775
| +476% | +$2.85M | ﹤0.01% | 2401 |
|
|
2024
Q4 | $620K | Sell |
18,005
-95,490
| -84% | -$3.29M | ﹤0.01% | 3584 |
|
|
2024
Q3 | $4.54M | Buy |
113,495
+96,727
| +577% | +$3.87M | ﹤0.01% | 2179 |
|
|
2024
Q2 | $506K | Buy |
16,768
+23
| +0.1% | +$694 | ﹤0.01% | 3574 |
|
|
2024
Q1 | $562K | Buy |
16,745
+1,267
| +8% | +$42.5K | ﹤0.01% | 3478 |
|
|
2023
Q4 | $500K | Buy |
15,478
+543
| +4% | +$17.5K | ﹤0.01% | 3523 |
|
|
2023
Q3 | $489K | Sell |
14,935
-26,999
| -64% | -$885K | ﹤0.01% | 3527 |
|
|
2023
Q2 | $1.48M | Buy |
41,934
+7,262
| +21% | +$256K | ﹤0.01% | 2988 |
|
|
2023
Q1 | $1.13M | Buy |
34,672
+9,831
| +40% | +$321K | ﹤0.01% | 3077 |
|
|
2022
Q4 | $1.37M | Buy |
24,841
+14,446
| +139% | +$796K | ﹤0.01% | 2875 |
|
|
2022
Q3 | $460K | Sell |
10,395
-4,307
| -29% | -$191K | ﹤0.01% | 3497 |
|
|
2022
Q2 | $717K | Sell |
14,702
-2,289
| -13% | -$112K | ﹤0.01% | 3314 |
|
|
2022
Q1 | $827K | Sell |
16,991
-7,478
| -31% | -$364K | ﹤0.01% | 3811 |
|
|
2021
Q4 | $1.04M | Sell |
24,469
-57,675
| -70% | -$2.46M | ﹤0.01% | 3810 |
|
|
2021
Q3 | $3.15M | Buy |
82,144
+72,383
| +742% | +$2.77M | ﹤0.01% | 3113 |
|
|
2021
Q2 | $276K | Buy |
9,761
+2,857
| +41% | +$80.8K | ﹤0.01% | 4606 |
|
|
2021
Q1 | $228K | Sell |
6,904
-26,312
| -79% | -$869K | ﹤0.01% | 4777 |
|
|
2020
Q4 | $1.2M | Buy |
33,216
+32,216
| +3,222% | +$1.16M | ﹤0.01% | 3832 |
|
|
2020
Q3 | $34K | Buy |
+1,000
| New | +$34K | ﹤0.01% | 5366 |
|